BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Quercetin
,
rs7903146
,
ZBTB7A
,
Apoptosis
,
Lung cancer
,
Breast
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
stemregenin 1
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
UQCRHL
RDH14
TPGS1
CCDC85B
ADAT3
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
MODULE_83
MODULE_114
HSIAO_HOUSEKEEPING_GENES
MODULE_151
BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Hematopoietic stem cells with zinc finger nuclease (ZFN) mediated HLA-A deficiency
Megakaryocyte productive cells CD34+ CD41+ and CD34+ CD41+ CD9- treated with AHR antagonist SR1
Acute myeloid leukemia cells treated with AhR agonists and antagonist
Explore Curated Studies Results
Literature
Most Relevant Literature
Reducing TGF-β1 cooperated with StemRegenin 1 promoted the expansion ex vivo of cord blood CD34+ cel…
Generation and function of progenitor T cells from StemRegenin-1-expanded CD34+ human hematopoietic …
AHR-mediated oxidative stress contributes to the cardiac developmental toxicity of trichloroethylene…
The aryl hydrocarbon receptor antagonist StemRegenin 1 promotes human plasmacytoid and myeloid dendr…
Aryl hydrocarbon receptor-dependent enrichment of a megakaryocytic precursor with a high potential t…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ